176 studies found for:    "Haemophilus influenzae"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine,Freeze-dried
Condition: Haemophilus Influenzae Type b Infections
Interventions: Biological: Minhai-HIB;   Biological: Act-HIB®
2 Completed Nontypeable H. Influenzae in Healthy Adults
Condition: Haemophilus Influenzae (NTHI)
Intervention: Biological: NTHi Strain 2019
3 Completed Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b
Condition: Haemophilus Influenzae Type b
Intervention: Biological: Haemophilus influenzae type b
4 Completed A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine
Condition: Haemophilus Influenza
Intervention: Biological: Hib conjugate vaccine
5 Completed Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b
Condition: Haemophilus Influenzae Type b
Interventions: Biological: Haemophilus influenzae type b vaccine;   Biological: Commercial Haemophilus influenzae type b vaccine
6 Completed Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China
Condition: Haemophilus Influenzae Type b (Hib) Infection
Interventions: Biological: Vaxem Hib (Haemophilus influenzae type b (Hib) vaccine);   Biological: Hiberix (Haemophilus influenzae type b (Hib) vaccine)
7 Completed
Has Results
Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine
Conditions: Haemophilus Influenzae Type b;   Neisseria Meningitidis
Interventions: Biological: Hib-MenCY-TT vaccine (MenHibrix);   Biological: Meningitec®;   Biological: ActHIB®;   Biological: Infanrix® Penta;   Biological: Prevenar®;   Biological: Mencevax® ACWY;   Biological: PRP (Polyribosyl Ribitol Phosphate)
8 Completed Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children
Condition: Haemophilus Influenzae Type B Infection
Intervention: Biological: Haemophilus influenza type b conjugate vaccine
9 Completed Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China
Condition: Haemophilus Influenzae Type b (Hib) Infection
Intervention: Biological: Haemophilus influenzae type b (Hib) vaccine
10 Completed
Has Results
Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults
Conditions: Diseases Caused by Streptococcus Pneumoniae and Nontypable Haemophilus Influenzae;   Haemophilus Influenzae-Streptococcus Pneumoniae Vaccine
Interventions: Biological: GSK2231395A;   Biological: Engerix-B
11 Completed
Has Results
Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)
Conditions: Haemophilus Influenzae Type B;   Hepatitis B
Interventions: Biological: Comparator: Modified Process Vaccine;   Biological: Comparator: COMVAX™
12 Completed
Has Results
Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children
Condition: Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b
Interventions: Biological: Hib-CRM197;   Biological: Hib-TT
13 Terminated Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine
Conditions: Haemophilus Influenzae;   Streptococcus Pneumoniae
Interventions: Biological: GSK2231395A;   Biological: TwinrixTM
14 Completed Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age
Condition: Infectious Disease by Haemophilus Influenzae Type b
Interventions: Biological: LBVH0101 (Hib vaccine);   Biological: Hiberix™ Vaccine
15 Completed Exploratory Clinical Study of MT-2301
Condition: Haemophilus Influenza Type b
Interventions: Biological: Haemophilus b conjugate vaccine diphteria CRM197 protein conjugate)-Low + DPT-IPV;   Biological: Haemophilus b conjugate vaccine diphteria CRM197 protein conjugate)-High + DPT-IPV;   Biological: Haemophilus influenza type b conjugate vaccine + DPT-IPV
16 Completed Study to Eliminate Hib Carriage in Rural Alaska Native Villages
Conditions: Haemophilus Influenzae Type B;   Carrier State
Intervention: Biological: Hib conjugate vaccine (HbOC, Wyeth Vaccines)
17 Completed
Has Results
Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age
Conditions: Haemophilus Influenzae Type b;   Neisseria Meningitidis
Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined 792014;   Biological: ActHIB;   Biological: Pediarix/Infanrix Penta
18 Completed
Has Results
Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
Conditions: Haemophilus Influenzae Type b;   Neisseria Meningitidis
Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine;   Biological: ActHIB;   Biological: PedvaxHIB;   Biological: Pediarix;   Biological: Prevnar;   Biological: M-M-R II;   Biological: Varivax
19 Completed
Has Results
3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age
Conditions: Haemophilus Influenzae Type b;   Neisseria Meningitidis
Interventions: Biological: Hib-MenCY-TT vaccine;   Biological: Hib-MenC-TT vaccine;   Biological: Menjugate ®;   Biological: Infanrix penta ®;   Biological: Infanrix hexa ®
20 Completed Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants
Condition: Haemophilus Influenzae Type b (Hib) Infection
Intervention: Biological: Haemophilus influenzae type b (Hib) vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.